Rhumbline Advisers Inogen Inc Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Inogen Inc stock. As of the latest transaction made, Rhumbline Advisers holds 39,059 shares of INGN stock, worth $339,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,059
Previous 36,498 7.02%
Holding current value
$339,422
Previous $260,000 5.38%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$5.75 - $7.32 $14,725 - $18,746
2,561 Added 7.02%
39,059 $274,000
Q1 2025

Apr 08, 2025
SELL
$6.8 - $12.53 $14,178 - $26,125
-2,085 Reduced 5.4%
36,498 $248,000
Q4 2024

May 29, 2025
BUY
$8.31 - $11.09 $17,326 - $23,122
2,085 Added 5.71%
38,583 $353,000
Q4 2024

Jan 30, 2025
BUY
$8.31 - $11.09 $6,016 - $8,029
724 Added 1.91%
38,583 $353,000
Q3 2024

Nov 12, 2024
SELL
$7.67 - $12.98 $12,394 - $20,975
-1,616 Reduced 4.09%
37,859 $367,000
Q2 2024

Aug 01, 2024
BUY
$6.3 - $8.95 $1,719 - $2,443
273 Added 0.7%
39,475 $320,000
Q1 2024

May 09, 2024
BUY
$5.26 - $10.15 $4,912 - $9,480
934 Added 2.44%
39,202 $316,000
Q4 2023

Feb 08, 2024
SELL
$4.21 - $6.32 $33,844 - $50,806
-8,039 Reduced 17.36%
38,268 $210,000
Q3 2023

Nov 09, 2023
BUY
$5.14 - $11.28 $4,816 - $10,569
937 Added 2.07%
46,307 $241,000
Q2 2023

Aug 08, 2023
SELL
$10.01 - $13.86 $307,777 - $426,153
-30,747 Reduced 40.39%
45,370 $524,000
Q1 2023

May 11, 2023
BUY
$11.88 - $26.0 $43,742 - $95,732
3,682 Added 5.08%
76,117 $950,000
Q4 2022

Feb 14, 2023
BUY
$19.14 - $24.55 $18,240 - $23,396
953 Added 1.33%
72,435 $1.43 Million
Q3 2022

Nov 10, 2022
BUY
$22.74 - $31.8 $150,720 - $210,770
6,628 Added 10.22%
71,482 $1.74 Million
Q2 2022

Aug 11, 2022
BUY
$22.88 - $35.28 $238,844 - $368,287
10,439 Added 19.18%
64,854 $1.57 Million
Q1 2022

May 12, 2022
BUY
$28.1 - $35.25 $68,030 - $85,340
2,421 Added 4.66%
54,415 $1.76 Million
Q4 2021

Feb 10, 2022
BUY
$29.66 - $44.0 $60,980 - $90,464
2,056 Added 4.12%
51,994 $1.77 Million
Q3 2021

Nov 12, 2021
SELL
$43.09 - $82.26 $198,989 - $379,876
-4,618 Reduced 8.46%
49,938 $2.15 Million
Q2 2021

Aug 05, 2021
SELL
$52.03 - $68.77 $231,065 - $305,407
-4,441 Reduced 7.53%
54,556 $3.56 Million
Q1 2021

May 06, 2021
BUY
$43.96 - $55.99 $5,846 - $7,446
133 Added 0.23%
58,997 $3.1 Million
Q4 2020

Feb 10, 2021
BUY
$27.19 - $44.68 $100,494 - $165,137
3,696 Added 6.7%
58,864 $2.63 Million
Q3 2020

Nov 12, 2020
SELL
$27.01 - $37.31 $85,108 - $117,563
-3,151 Reduced 5.4%
55,168 $1.6 Million
Q2 2020

Aug 13, 2020
BUY
$32.85 - $53.77 $10,413 - $17,045
317 Added 0.55%
58,319 $2.07 Million
Q1 2020

May 06, 2020
BUY
$32.63 - $67.59 $16,249 - $33,659
498 Added 0.87%
58,002 $3 Million
Q4 2019

Feb 05, 2020
BUY
$45.95 - $76.15 $176,172 - $291,959
3,834 Added 7.14%
57,504 $3.93 Million
Q3 2019

Oct 23, 2019
SELL
$41.82 - $66.71 $55,244 - $88,123
-1,321 Reduced 2.4%
53,670 $2.57 Million
Q2 2019

Aug 14, 2019
BUY
$63.19 - $95.15 $41,263 - $62,132
653 Added 1.2%
54,991 $3.67 Million
Q1 2019

May 01, 2019
BUY
$90.12 - $152.23 $142,299 - $240,371
1,579 Added 2.99%
54,338 $5.18 Million
Q4 2018

Jan 31, 2019
BUY
$112.83 - $239.74 $2.05 Million - $4.35 Million
18,131 Added 52.36%
52,759 $6.55 Million
Q3 2018

Nov 07, 2018
SELL
$189.1 - $282.92 $1.38 Million - $2.06 Million
-7,282 Reduced 17.38%
34,628 $8.45 Million
Q2 2018

Aug 06, 2018
BUY
$123.8 - $192.48 $239,057 - $371,678
1,931 Added 4.83%
41,910 $7.81 Million
Q1 2018

May 02, 2018
BUY
$114.22 - $133.22 $101,770 - $118,699
891 Added 2.28%
39,979 $4.91 Million
Q4 2017

Feb 09, 2018
BUY
$93.4 - $128.74 $520,798 - $717,854
5,576 Added 16.64%
39,088 $4.66 Million
Q3 2017

Nov 06, 2017
BUY
$91.08 - $104.49 $3.05 Million - $3.5 Million
33,512
33,512 $3.19 Million

Others Institutions Holding INGN

# of Institutions
135
Shares Held
20.7M
Call Options Held
17.3K
Put Options Held
10K
View Full List

About Inogen Inc

INGN Quotes by TradingView
  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $199M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email